The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2016
Filed:
Oct. 13, 2015
Applicant:
The United States of America, As Represented BY the Secretary, Dept. of Health and Human Services, Washington, DC (US);
Inventors:
Enrique Zudaire, Germantown, MD (US);
Marta Aparicio, Rockville, MD (US);
Frank Cuttitta, Adamstown, MD (US);
Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61K 31/135 (2006.01); A61K 31/4015 (2006.01); A61K 31/5365 (2006.01); A61K 31/285 (2006.01); A61K 31/555 (2006.01); A61K 31/63 (2006.01); A61K 31/10 (2006.01); A61K 31/445 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/12 (2013.01); A61K 31/10 (2013.01); A61K 31/135 (2013.01); A61K 31/285 (2013.01); A61K 31/4015 (2013.01); A61K 31/445 (2013.01); A61K 31/5365 (2013.01); A61K 31/555 (2013.01); A61K 31/63 (2013.01); A61K 45/06 (2013.01);
Abstract
Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.